These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 34420077)
1. Rivaroxaban versus Vitamin K Antagonists (warfarin) based on the triple therapy for left ventricular thrombus after ST-Elevation myocardial infarction. Zhang Z; Si D; Zhang Q; Qu M; Yu M; Jiang Z; Li D; Yang P; Zhang W Heart Vessels; 2022 Mar; 37(3):374-384. PubMed ID: 34420077 [TBL] [Abstract][Full Text] [Related]
2. Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus After Anterior ST-Segment Elevation Myocardial Infarction. Zhang Z; Si D; Zhang Q; Jin L; Zheng H; Qu M; Yu M; Jiang Z; Li D; Li S; Yang P; He Y; Zhang W JACC Cardiovasc Interv; 2022 Apr; 15(8):861-872. PubMed ID: 35367170 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus After Acute Anterior Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Intervention. Liang J; Wang Z; Zhou Y; Shen H; Chai M; Ma X; Han H; Shao Q; Li Q Curr Vasc Pharmacol; 2022; 20(6):517-526. PubMed ID: 36200193 [TBL] [Abstract][Full Text] [Related]
4. Rationale and design of a prospective multi-center randomized trial of EARLY treatment by rivaroxaban versus warfarin in ST-segment elevation MYOcardial infarction with Left Ventricular Thrombus (EARLY-MYO-LVT trial). He J; Ge H; Dong JX; Zhang W; Kong LC; Qiao ZQ; Zheng Y; Ding S; Wan F; Shen L; Wang W; Gu ZC; Yang F; Li Z; Pu J Ann Transl Med; 2020 Mar; 8(6):392. PubMed ID: 32355836 [TBL] [Abstract][Full Text] [Related]
5. The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction. Jones DA; Wright P; Alizadeh MA; Fhadil S; Rathod KS; Guttmann O; Knight C; Timmis A; Baumbach A; Wragg A; Mathur A; Antoniou S Eur Heart J Cardiovasc Pharmacother; 2021 Sep; 7(5):398-404. PubMed ID: 32730627 [TBL] [Abstract][Full Text] [Related]
6. Incidence and outcomes of early left ventricular thrombus following ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Khoury S; Carmon S; Margolis G; Keren G; Shacham Y Clin Res Cardiol; 2017 Sep; 106(9):695-701. PubMed ID: 28396990 [TBL] [Abstract][Full Text] [Related]
8. Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial. Kerneis M; Yee MK; Mehran R; Nafee T; Bode C; Halperin JL; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Cohen M; Fox KAA; Gibson CM Circ Cardiovasc Interv; 2019 Nov; 12(11):e008160. PubMed ID: 31707805 [TBL] [Abstract][Full Text] [Related]
9. Left ventricular thrombus after acute ST-segment elevation myocardial infarction: multi-parametric cardiac magnetic resonance imaging with long-term outcomes. Shi RY; Chen BH; Wu CW; Wesemann L; Hu J; Xu JR; Zhou Y; Tao Q; Wu LM Int J Cardiovasc Imaging; 2022 Nov; 38(11):2373-2384. PubMed ID: 36434326 [TBL] [Abstract][Full Text] [Related]
10. [Related factors of left ventricular thrombus formation within two weeks in patients with acute ST-segment elevation myocardial infarction and left ventricular aneurysm]. Guo YY; Zhao X; Wang L; Zhao XY Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Apr; 49(4):360-367. PubMed ID: 33874686 [No Abstract] [Full Text] [Related]
11. Value of the platelet-to-lymphocyte ratio in the prediction of left ventricular thrombus in anterior ST-elevation myocardial infarction with left ventricular dysfunction. Zhang Q; Si D; Zhang Z; Wang C; Zheng H; Li S; Huang S; Zhang W BMC Cardiovasc Disord; 2020 Sep; 20(1):428. PubMed ID: 32993501 [TBL] [Abstract][Full Text] [Related]
12. Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention. Kerneis M; Yee MK; Mehran R; Nafee T; Bode C; Halperin JL; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Cohen M; Fox KAA; Gibson CM Circ Cardiovasc Interv; 2019 Feb; 12(2):e007124. PubMed ID: 30704287 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic Anticoagulation to Prevent Left Ventricular Thrombus Following Acute Myocardial Infarction: A Systematic Review and Meta-Analysis. Sacoransky E; Ke DYJ; Alexander B; Abuzeid W Am J Cardiol; 2024 Apr; 217():10-17. PubMed ID: 38412882 [TBL] [Abstract][Full Text] [Related]
14. Left ventricular thrombosis in acute anterior myocardial infarction: Evaluation of hospital mortality, thromboembolism, and bleeding. Ram P; Shah M; Sirinvaravong N; Lo KB; Patil S; Patel B; Tripathi B; Garg L; Figueredo V Clin Cardiol; 2018 Oct; 41(10):1289-1296. PubMed ID: 30084493 [TBL] [Abstract][Full Text] [Related]
15. Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial. Schwalm JD; Ahmad M; Salehian O; Eikelboom JW; Natarajan MK J Thromb Thrombolysis; 2010 Aug; 30(2):127-32. PubMed ID: 20157843 [TBL] [Abstract][Full Text] [Related]
16. Predictive Utility of Left Heart Catheterization Indices for Left Ventricular Thrombus Formation After Anterior ST-Elevation Myocardial Infarction. Tan S; Thakur U; Chow KY; Lee S; Ngoi A; Nerlekar N; Nasis A Cardiovasc Revasc Med; 2022 Jan; 34():106-111. PubMed ID: 33461935 [TBL] [Abstract][Full Text] [Related]
17. Contemporary incidence and predictors of left ventricular thrombus in patients with anterior acute myocardial infarction. Boivin-Proulx LA; Ieroncig F; Demers SP; Nozza A; Soltani M; Ghersi I; Verreault-Julien L; Alansari Y; Massie C; Simard P; Rosca L; Lalancette JS; Massicotte G; Chen-Tournoux A; Daneault B; Paradis JM; Diodati JG; Pranno N; Jolicoeur M; Potter BJ; Marquis-Gravel G Clin Res Cardiol; 2023 Apr; 112(4):558-565. PubMed ID: 36651998 [TBL] [Abstract][Full Text] [Related]
18. Prophylactic warfarin therapy after primary percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction. Le May MR; Acharya S; Wells GA; Burwash I; Chong AY; So DY; Glover CA; Froeschl MPV; Hibbert B; Marquis JF; Dick A; Blondeau M; Bernick J; Labinaz M JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):155-162. PubMed ID: 25616920 [TBL] [Abstract][Full Text] [Related]
19. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial. Kerneis M; Gibson CM; Chi G; Mehran R; AlKhalfan F; Talib U; Pahlavani S; Mir M; Bode C; Halperin JL; Nafee T; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Fox KAA; Cohen M JACC Cardiovasc Interv; 2018 Apr; 11(7):626-634. PubMed ID: 29550085 [TBL] [Abstract][Full Text] [Related]
20. Left Ventricular Thrombus Management After Acute Myocardial Infarction in Clinical Practice: Results from LEVITATION Survey and Narrative Review. Di Odoardo LAF; Bianco M; Gil IJN; Motolese IG; Chinaglia A; Vicenzi M; Carugo S; Stefanini GG; Cerrato E Cardiovasc Drugs Ther; 2024 Jun; 38(3):483-492. PubMed ID: 36538031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]